ID   SOX2_DANRE              Reviewed;         315 AA.
AC   Q6P0E1;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   07-APR-2021, entry version 115.
DE   RecName: Full=Transcription factor Sox-2;
GN   Name=sox2 {ECO:0000312|EMBL:AAH65656.1}; ORFNames=zgc:65860, zgc:77389;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAE48583.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RC   TISSUE=Embryo {ECO:0000269|PubMed:16408288};
RX   PubMed=16408288; DOI=10.1002/dvdy.20678;
RA   Okuda Y., Yoda H., Uchikawa M., Furutani-Seiki M., Takeda H., Kondoh H.,
RA   Kamachi Y.;
RT   "Comparative genomic and expression analysis of group B1 sox genes in
RT   zebrafish indicates their diversification during vertebrate evolution.";
RL   Dev. Dyn. 235:811-825(2006).
RN   [2] {ECO:0000312|EMBL:AAH65656.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo {ECO:0000312|EMBL:AAH56743.1};
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16543359; DOI=10.1093/hmg/ddl064;
RA   Williamson K.A., Hever A.M., Rainger J., Rogers R.C., Magee A., Fiedler Z.,
RA   Keng W.T., Sharkey F.H., McGill N., Hill C.J., Schneider A., Messina M.,
RA   Turnpenny P.D., Fantes J.A., van Heyningen V., Fitzpatrick D.R.;
RT   "Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome.";
RL   Hum. Mol. Genet. 15:1413-1422(2006).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=16324829; DOI=10.1016/j.mod.2005.10.005;
RA   Cunliffe V.T., Casaccia-Bonnefil P.;
RT   "Histone deacetylase 1 is essential for oligodendrocyte specification in
RT   the zebrafish CNS.";
RL   Mech. Dev. 123:24-30(2006).
CC   -!- FUNCTION: Transcriptional activator. May function as a switch in
CC       neuronal development (By similarity). Downstream SRRT target that
CC       mediates the promotion of neural stem cell self-renewal (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:16408288}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267,
CC       ECO:0000269|PubMed:16543359, ECO:0000305}. Cytoplasm
CC       {ECO:0000269|PubMed:16543359}.
CC   -!- TISSUE SPECIFICITY: At the shield stage, expressed uniformly in the
CC       future ectoderm. At the 75-80% epiboly stage, becomes localized to the
CC       presumptive neuroectoderm; strong expression in the presumptive
CC       forebrain, weak expression in the presumptive spinal cord. At the tail
CC       bud to 3-somite stage, expressed in distinct regions of the future
CC       brain, the anterior margin of the neural plate and the future retina.
CC       At the 12-somite stage, strong expression in the central nervous system
CC       rostral to the hindbrain, including the optic vesicle. At the 21- to
CC       25-somite stage, strong expression in the retina, otic placode and
CC       cerebellum. At 28-50 hours post-fertilization, restricted to the
CC       ventricular zone of the hindbrain. At 5 days, expressed in the
CC       esophageal endoderm. {ECO:0000269|PubMed:16324829,
CC       ECO:0000269|PubMed:16408288, ECO:0000269|PubMed:16543359}.
CC   -!- DEVELOPMENTAL STAGE: Expressed zygotically. First detected at the 30%
CC       epiboly stage. {ECO:0000269|PubMed:16408288}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB242329; BAE48583.1; -; mRNA.
DR   EMBL; BC056743; AAH56743.1; -; mRNA.
DR   EMBL; BC065656; AAH65656.1; -; mRNA.
DR   RefSeq; NP_998283.1; NM_213118.1.
DR   SMR; Q6P0E1; -.
DR   STRING; 7955.ENSDARP00000095266; -.
DR   PaxDb; Q6P0E1; -.
DR   Ensembl; ENSDART00000104493; ENSDARP00000095266; ENSDARG00000070913.
DR   GeneID; 378723; -.
DR   KEGG; dre:378723; -.
DR   CTD; 6657; -.
DR   ZFIN; ZDB-GENE-030909-1; sox2.
DR   eggNOG; KOG0527; Eukaryota.
DR   GeneTree; ENSGT00940000160614; -.
DR   HOGENOM; CLU_021123_0_0_1; -.
DR   InParanoid; Q6P0E1; -.
DR   OMA; QHYQGAP; -.
DR   OrthoDB; 1161594at2759; -.
DR   PhylomeDB; Q6P0E1; -.
DR   TreeFam; TF351735; -.
DR   Reactome; R-DRE-3769402; Deactivation of the beta-catenin transactivating complex.
DR   PRO; PR:Q6P0E1; -.
DR   Proteomes; UP000000437; Chromosome 22.
DR   Bgee; ENSDARG00000070913; Expressed in retina and 83 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription regulator complex; IC:ZFIN.
DR   GO; GO:0003682; F:chromatin binding; IDA:ZFIN.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:ZFIN.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008283; P:cell population proliferation; IMP:ZFIN.
DR   GO; GO:0021538; P:epithalamus development; IMP:ZFIN.
DR   GO; GO:0048592; P:eye morphogenesis; IMP:ZFIN.
DR   GO; GO:0031101; P:fin regeneration; IMP:ZFIN.
DR   GO; GO:0030900; P:forebrain development; IBA:GO_Central.
DR   GO; GO:0048839; P:inner ear development; IBA:GO_Central.
DR   GO; GO:0060119; P:inner ear receptor cell development; IMP:ZFIN.
DR   GO; GO:1905040; P:otic placode development; IMP:ZFIN.
DR   GO; GO:0071599; P:otic vesicle development; IMP:ZFIN.
DR   GO; GO:0021982; P:pineal gland development; IMP:ZFIN.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:ZFIN.
DR   GO; GO:0031099; P:regeneration; IMP:ZFIN.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   Gene3D; 1.10.30.10; -; 1.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR032643; SOX-2.
DR   InterPro; IPR022097; SOX_fam.
DR   PANTHER; PTHR10270:SF231; PTHR10270:SF231; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   Pfam; PF12336; SOXp; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Cytoplasm; Developmental protein; DNA-binding; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN           1..315
FT                   /note="Transcription factor Sox-2"
FT                   /id="PRO_0000238911"
FT   DNA_BIND        38..106
FT                   /note="HMG box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00267"
FT   COMPBIAS        243..248
FT                   /note="Poly-Ser"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   315 AA;  34698 MW;  E398DB33C43330EA CRC64;
     MYNMMETELK PPAPQPNTGG TGNTNSSGNN QKNSPDRIKR PMNAFMVWSR GQRRKMAQEN
     PKMHNSEISK RLGAEWKLLS ESEKRPFIDE AKRLRALHMK EHPDYKYRPR RKTKTLMKKD
     KYTLPGGLLA PGGNGMGAGV GVGAGLGAGV NQRMDSYAHM NGWTNGGYGM MQEQLGYPQH
     PSLNAHNTAQ MQPMHRYDMS ALQYNSMTNS QTYMNGSPTY SMSYSQQSTP GMTLGSMGSV
     VKSESSSSPP VVTSSSHSRA GQCQTGDLRD MISMYLPGAE VQDQSAQSRL HMSQHYQSAP
     VPGTTINGTI PLSHM
//
